Defining the natural history of uremic cardiomyopathy in chronic kidney disease: The role of cardiovascular magnetic resonance

JACC: Cardiovascular Imaging

Volumn 7, Issue 7, 2014, Pages 703-714

  Edwards, Nicola C ^a   Moody, William E ^a   Chue, Colin D ^a   Ferro, Charles J ^a   Townend, Jonathan N ^a   Steeds, Richard P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

cardiac magnetic resonance; chronic kidney disease; uremic cardiomyopathy

Indexed keywords

GADOLINIUM;

ARTERIAL STIFFNESS; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; END STAGE RENAL DISEASE; HEART VENTRICLE FUNCTION; HUMAN; NEPHROGENIC SYSTEMIC FIBROSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TRANSTHORACIC ECHOCARDIOGRAPHY; CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; COMPLICATION; DIAGNOSTIC USE; FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RISK; RISK FACTOR;

CARDIOMYOPATHIES; CARDIOVASCULAR DISEASES; FIBROSIS; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; ODDS RATIO; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84904568526     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2013.09.025     Document Type: Review

References (54)

1. J. Coresh, E. Selvin, and L.A. Stevens et al. Prevalence of chronic kidney disease in the United States JAMA 298 2007 2038 2047
2. K. Matsushita, M. van der Velde, and B.C. Astor et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
3. U.S. Renal Data System (USRDS) Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2013 National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
4. C. Baigent, M.J. Landray, and C. Reith et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 2011 2181 2192
5. R.N. Foley, P.S. Parfrey, and J.D. Harnett et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy Kidney Int 47 1995 186 192
6. R.N. Foley, P.S. Parfrey, J.D. Harnett, G.M. Kent, D.C. Murray, and P.E. Barre The prognostic importance of left ventricular geometry in uremic cardiomyopathy J Am Soc Nephrol 5 1995 2024 2031
7. P. Hunold, F.M. Vogt, U.W. Heemann, U. Zimmermann, and J. Barkhausen Myocardial mass and volume measurement of hypertrophic left ventricles by MRI: study in dialysis patients examined before and after dialysis J Cardiovasc Magn Reson 5 2003 553 561
8. G.A. Stewart, J. Foster, and M. Cowan et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging Kidney Int 56 1999 2248 2253
9. P.B. Mark, N. Johnston, and B.A. Groenning et al. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging Kidney Int 69 2006 1839 1845
10. P.S. Parfrey, R.N. Foley, J.D. Harnett, G.M. Kent, D.C. Murray, and P.E. Barre Outcome and risk factors for left ventricular disorders in chronic uraemia Nephrol Dial Transplant 11 1996 1277 1285
11. H.J. Simpson, S.J. Gandy, J.G. Houston, N.S. Rajendra, J.I. Davies, and A.D. Struthers Left ventricular hypertrophy: reduction of blood pressure already in the normal range further regresses left ventricular mass Heart 96 2010 148 152
12. G.M. London, B. Pannier, and A.P. Guerin et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study J Am Soc Nephrol 12 2001 2759 2767
13. D. Montanaro, M. Gropuzzo, and P. Tulissi et al. Effects of successful renal transplantation on left ventricular mass Transplant Proc 37 2005 2485 2487
14. R.K. Patel, P.B. Mark, N. Johnston, E. McGregor, H.J. Dargie, and A.G. Jardine Renal transplantation is not associated with regression of left ventricular hypertrophy: a magnetic resonance study Clin J Am Soc Nephrol 3 2008 1807 1811
15. M. Park, C.Y. Hsu, and Y. Li et al. Associations between kidney function and subclinical cardiac abnormalities in CKD J Am Soc Nephrol 23 2012 1725 1734
16. C.D. Chue, N.C. Edwards, W.E. Moody, R.P. Steeds, J.N. Townend, and C.J. Ferro Serum phosphate is associated with left ventricular mass in patients with chronic kidney disease: a cardiac magnetic resonance study Heart 98 2012 219 224
17. N.C. Edwards, C.J. Ferro, J.N. Townend, and R.P. Steeds Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction Heart 94 2008 1038 1043
18. R.K. Patel, S. Oliver, and P.B. Mark et al. Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging Clin J Am Soc Nephrol 4 2009 1477 1483
19. E.P. McQuarrie, E.M. Freel, P.B. Mark, R. Fraser, J.M. Connell, and A.G. Jardine Urinary sodium excretion is the main determinant of mineralocorticoid excretion rates in patients with chronic kidney disease Nephrol Dial Transplant 28 2013 1526 1532
20. P.M. Okin, R.B. Devereux, and S. Jern et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention for Endpoint reduction in Hypertension (LIFE) study Circulation 108 2003 684 690
21. N.C. Edwards, R.P. Steeds, P.M. Stewart, C.J. Ferro, and J.N. Townend Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial J Am Coll Cardiol 54 2009 505 512
22. K.K. Stevens, E.P. McQuarrie, and W. Sands et al. Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formation Int J Nephrol 2011 2011 297070
23. S. Corda, A. Mebazaa, and M.P. Gandolfini et al. Trophic effect of human pericardial fluid on adult cardiac myocytes: differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy Circ Res 81 1997 679 687
24. C.D. Chue, N.A. Wall, and N.J. Crabtree et al. Aortic calcification and femoral bone density are independently associated with left ventricular mass in patients with chronic kidney disease PLoS One 7 2012 e39241
25. R. Thadhani, E. Appelbaum, and Y. Pritchett et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial JAMA 307 2012 674 684
26. B.J. Schietinger, G.M. Brammer, and H. Wang et al. Patterns of late gadolinium enhancement in chronic hemodialysis patients J Am Coll Cardiol Img 1 2008 450 456
27. N.C. Edwards, C.J. Ferro, J.N. Townend, and R.P. Steeds Myocardial disease in systemic vasculitis and autoimmune disease detected by cardiovascular magnetic resonance Rheumatology (Oxford) 46 2007 1208 1209
28. J. Aoki, Y. Ikari, and H. Nakajima et al. Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients Kidney Int 67 2005 333 340
29. A.M. Maceira, and R.H. Mohiaddin Cardiovascular magnetic resonance in systemic hypertension J Cardiovasc Magn Reson 14 2012 28
30. A. Rudolph, H. Abdel-Aty, and S. Bohl et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling J Am Coll Cardiol 53 2009 284 291
31. D.J. Rakhit, X.H. Zhang, R. Leano, K.A. Armstrong, N.M. Isbel, and T.H. Marwick Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease Am Heart J 153 2007 656 664
32. N.C. Edwards, A. Hirth, C.J. Ferro, J.N. Townend, and R.P. Steeds Subclinical abnormalities of left ventricular myocardial deformation in early-stage chronic kidney disease: the precursor of uremic cardiomyopathy? J Am Soc Echocardiogr 21 2008 1293 1298
33. N.C. Edwards Impaired circumferential and longitudinal myocardial deformation in ealy stage chronic kidney disease: the earliest features of uremic cardiomyopathy J Cardiovasc Magn Reson 15 2013 153
34. H. Wang, J. Liu, and X.D. Yao et al. Multidirectional myocardial systolic function in hemodialysis patients with preserved left ventricular ejection fraction and different left ventricular geometry Nephrol Dial Transplant 27 2012 4422 4429
35. F.L. Dini, R.T. Demmer, and A. Simioniuc et al. Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure Eur J Heart Fail 14 2012 287 294
36. F. Paneni, M. Gregori, and G.M. Ciavarella et al. Right ventricular dysfunction in patients with end-stage renal disease Am J Nephrol 32 2010 432 438
37. B. Kawar, T. Ellam, C. Jackson, and D.G. Kiely Pulmonary hypertension in renal disease: epidemiology, potential mechanisms and implications Am J Nephrol 37 2013 281 290
38. W.E. Moody, N.C. Edwards, C.D. Chue, C.J. Ferro, and J.N. Townend Arterial disease in chronic kidney disease Heart 99 2013 365 372
39. J. Blacher, A.P. Guerin, B. Pannier, S.J. Marchais, M.E. Safar, and G.M. London Impact of aortic stiffness on survival in end-stage renal disease Circulation 99 1999 2434 2439
40. M.C. Wang, W.C. Tsai, J.Y. Chen, and J.J. Huang Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease Am J Kidney Dis 45 2005 494 501
41. M. Briet, E. Bozec, and S. Laurent et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease Kidney Int 69 2006 350 357
42. L.U. Zimmerli, P.B. Mark, and T. Steedman et al. Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study Kidney Int 71 2007 68 73
43. P.B. Mark, A. Doyle, and K.G. Blyth et al. Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease J Cardiovasc Magn Reson 10 2008 39
44. C.D. Chue, N.C. Edwards, C.J. Ferro, J.N. Townend, and R.P. Steeds Effects of age and chronic kidney disease on regional aortic distensibility: a cardiovascular magnetic resonance study Int J Cardiol 168 2013 4249 4254
45. R.K. Patel, A.G. Jardine, and P.B. Mark et al. Association of left atrial volume with mortality among ESRD patients with left ventricular hypertrophy referred for kidney transplantation Am J Kidney Dis 55 2010 1088 1096
46. R.K. Patel, P.B. Mark, and G. Macnaught et al. Altered relative concentrations of high-energy phosphates in patients with uraemic cardiomyopathy measured by magnetic resonance spectroscopy Nephrol Dial Transplant 27 2012 2446 2451
47. T. Reiter, O. Ritter, and M.R. Prince et al. Minimizing risk of nephrogenic systemic fibrosis in cardiovascular magnetic resonance J Cardiovasc Magn Reson 14 2012 31
48. L.P. Golding, and J.M. Provenzale Nephrogenic systemic fibrosis: possible association with a predisposing infection AJR Am J Roentgenol 190 2008 1069 1075
49. D.R. Martin, S.K. Krishnamoorthy, and B. Kalb et al. Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols J Magn Reson Imaging 31 2010 440 446
50. E.L. Schiffrin, M.L. Lipman, and J.F. Mann Chronic kidney disease: effects on the cardiovascular system Circulation 116 2007 85 97
51. R.J. Glassock, R. Pecoits-Filho, and S.H. Barberato Left ventricular mass in chronic kidney disease and ESRD Clin J Am Soc Nephrol 4 Suppl 1 2009 S79 S91
52. C.D. Chue, J.N. Townend, and W.E. Moody et al. Cardiovascular effects of sevelamer in stage 3 CKD J Am Soc Nephrol 24 2013 842 852
53. N.C. Edwards, C.J. Ferro, and H. Kirkwood et al. Effect of spironolactone on left ventricular systolic and diastolic function in patients with early stage chronic kidney disease Am J Cardiol 106 2010 1505 1511
54. E.P. McQuarrie, R.K. Patel, and P.B. Mark et al. Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease Nephrol Dial Transplant 26 2011 933 938